Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

Clinical trial NCT02303730 · COMPLETED

Trial details

NCT number: NCT02303730
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Non-alcoholic Fatty Liver Disease

Start date: 2015-03-01
Primary completion: 2017-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.